Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ETR/SBS stock hub

ETR/SBS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/SBSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

215.2M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/SBS

In the news

Latest news · ETR/SBS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.7

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-0.1

P25 -6.7P50 8.5P75 17.2

ROIC-0.2

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/SBS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

EUR

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	1,343
Employees Change	-44%
Employees Change Percent	-3.17
Enterprise value	EUR 324.2M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	DE000STRA555
Last refreshed	2026-05-10
Market cap	EUR 215.2M
Price	EUR 17.7
Price currency	EUR
Rev Per Employee	186,793x
Sector	Healthcare
Sic	3826
Symbol	etr/SBS
Website	https://www.stratec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.11%
EV Earnings	-1,339.81x
EV/EBIT	19.52x
EV/EBITDA	10.14x
EV/FCF	-33.39x
EV/Sales	1.29x
FCF yield	-4.51%
Forward P/E	12.7x
P/B ratio	0.91x
P/S ratio	0.86x
PE Ratio10 Y	41.34x
PE Ratio3 Y	32.76x
PE Ratio5 Y	34.06x
PEG ratio	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.62%
EBITDA Margin	11.31%
Gross margin	25.6%
Gross Profit	EUR 64.2M
Gross Profit Growth	-15.93%
Gross Profit Growth Q	-34.84%
Gross Profit Growth3 Y	-6.86%
Gross Profit Growth5 Y	-1.42%
Net Income	EUR -242,000
Net Income Growth Years	0%
Pretax Margin	1.93%
Profit Margin	-0.1%
Profit Per Employee	EUR -180
ROA	2.38
Roa5y	5.3
ROCE	4.46
ROE	-0.1
Roe5y	9.58
ROIC	-0.24
Roic5y	8.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.68%
Cagr15y	-2.26%
Cagr1y	-24.42%
Cagr20y	-3.33%
Cagr3y	-33.41%
Cagr5y	-30.16%
Div CAGR10	-2.21%
Div CAGR3	-14.8%
Div CAGR5	-7.79%
EPS Growth Years	0
OCF Growth Q	-95.7%
Revenue Growth	-2.62x
Revenue Growth Q	-11.09x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.97x
Revenue Growth5 Y	0.06x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.58
Assets	EUR 426M
Cash	EUR 23.1M
Current Assets	EUR 213.4M
Current Liabilities	EUR 53.7M
Debt	EUR 132.1M
Debt EBITDA	EUR 4.13
Debt Equity	EUR 0.56
Debt FCF	EUR -13.61
Equity	EUR 237.3M
Interest Coverage	4.06
Liabilities	EUR 188.7M
Long Term Assets	EUR 212.6M
Long Term Liabilities	EUR 134.9M
Net Cash	EUR -109.1M
Net Cash By Market Cap	EUR -50.69
Net Debt EBITDA	EUR 3.85
Net Debt Equity	EUR 0.46
Tangible Book Value	EUR 129.4M
Tangible Book Value Per Share	EUR 10.64
WACC	5.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.97
Inventory Turnover	1.59
Net Working Capital	EUR 161.1M
Quick ratio	1.79
Working Capital	EUR 159.7M
Working Capital Turnover	EUR 1.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	EUR 0.6
Dividend Years	23
Dividend Yield	3.39%
Ex Div Date	2026-06-24
Last Dividend	EUR 0.6
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-59.65%
1Y total return	-24.4%
200-day SMA	23.13
3Y total return	-70.48%
50-day SMA	18.59
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.38%
All Time High	147.4
All Time High Change	-87.99%
All Time High Date	2021-09-03
All Time Low	1.36
All Time Low Change	1,201.47%
All Time Low Date	2000-12-28
ATR	0.96
Beta	0.79
Beta1y	1.74
Beta2y	1.59
Ch YTD	-21.16
High	17.9
High52	33.1
High52 Date	2025-10-07
High52ch	-46.53%
Low	17.62
Low52	16.34
Low52 Date	2026-05-06
Low52ch	8.32%
Ma50ch	-4.78%
Price vs 200-day SMA	-23.49%
RSI	46.13
RSI Monthly	29.36
RSI Weekly	38.06
Sharpe ratio	-0.52x
Sortino ratio	-0.64
Total Return	3.39%
Tr YTD	-21.16
Tr15y	-29%
Tr1m	4.98%
Tr1w	4.61%
Tr3m	-15.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 16.6M
Operating Income Growth	-38.2
Operating Income Growth Q	-53.04
Operating Income Growth3 Y	-27.25
Operating Income Growth5 Y	-13.36
Operating margin	6.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,630,664%
Net Borrowing	991,000
Shares Insiders	30.93%
Shares Institutions	30.41%
Shares Out	12,155,942
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -9.7M
Average Volume	11,826.35x
Bv Per Share	19.52
CAPEX	EUR -9.3M
Ch10y	-64.61
Ch15y	-41.65
Ch1m	4.98
Ch1w	4.61
Ch1y	-26.1
Ch20y	-61.35
Ch3m	-15.91
Ch3y	-71.95
Ch5y	-84.47
Ch6m	-9.88
Change	-0.45%
Change From Open	-0.67
Close	17.78
Days Gap	0.22
Depreciation Amortization	11,748,000
Dollar Volume	281,376.9
Earnings Date	2026-04-28
EBIT	EUR 16.6M
EBITDA	EUR 28.4M
EPS	EUR -0.02
F Score	3
FCF	EUR -9.7M
FCF EV Yield	-3x
FCF Per Share	EUR -0.8
Financing CF	-6,302,000
Fiscal Year End	December
Founded	1,979
Goodwill	49,853,000
Income Tax	EUR 5.1M
Investing CF	-16,804,000
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2025-12-31
Ma150	21.73
Ma150ch	-18.55%
Ma20	18.23
Ma20ch	-2.9%
Net CF	-24,108,000
Next Earnings Date	2026-05-11
Open	17.82
Payment Date	2026-06-26
Position In Range	28.57
Ppne	63,046,000
Price Date	2026-05-08
Price EBITDA	EUR 7.59
Ptbv Ratio	1.66
Relative Volume	1.39x
Revenue	250,863,000x
Tax By Revenue	2.03x
Tax Rate	104.99%
Tr20y	-49.22%
Tr6m	-9.88%
Volume	15,897
Z Score	2.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/SBS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$0.60 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.8%

1 consecutive years of growth

Total shareholder yield

+3.4%

Next ex-dividend date: 2026-06-24

Performance

ETR/SBS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/SBS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.4%

Share of float held by funds and institutions

Insider ownership

+30.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/SBS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

-23.5%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

-0.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/SBS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/SBS stock rating?

etr/SBS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/SBS analysis?

The full report lives at /stocks/etr/SBS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/SBS?

The latest report frames etr/SBS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/SBS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.